Pharmacology of the Microbiome 2017

Call for Papers: Pharmacology of the Microbiome: new targets for therapeutics Themed Issue

British Journal of Pharmacology will be publishing a special 'Themed Issue' entitled 'Pharmacology of the Microbiome: new targets for therapeutics', with Dr Niall Hyland and Prof. John Cryan as Guest Editors.

In this issue on Pharmacology of the Microbiome, we will provide an up-to-date account of harnessing the microbiome as a therapeutic strategy in disease and as a novel source for drug discovery efforts.

The issue will include authoritative state of the art review articles from:

  • Prof. Timothy Dinan 'Development of Psychobiotics'

  • Prof. William Wade 'The Nitrate-reducing Oral Microbiome: Novel Target in Therapeutics of Disease'

  • Dr. Elisabeth Bik 'Targeting the Gut Microbiome for Therapeutic Benefit'

  • Professor Andrew Patterson ‘Drug Metabolism and the Microbiota’

  • Dr. Brendan Griffin ‘Influence of the Gut Microbiota on Antipsychotic Efficacy’

  • Prof. Sean Davies ‘Therapeutic Modification of Gut Bacteria’

  • Prof. Colin Hill ‘Phages of life - the path to pharma’

Deadline for submissions was 11th September 2017.

Please click here for more information.